http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508123-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91205e61fba2db0e61efc04f029abf55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34f094670dacfc1c70350b9e58482e3f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 |
| filingDate | 2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4405eec8ce0ebaa9e198d9070f969eea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449746c1768ca320f810019ad48c22cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf94e563d5b9485ae9cbf37e5f92c07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3b6d8d49bb8d0b59cfa86f9ccbc3aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81885e8f4367e2c090fa20eddecd57af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe22c3be263775d8dbbcd95f24c3ac24 |
| publicationDate | 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2508123-C1 |
| titleOfInvention | Pharmaceutical composition for local application in treating inflammatory eye diseases and method for using it |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions refers to medicine and chemical-pharmaceutical industry. The group of inventions refers to pharmaceutical composition for local application and containing an active ingredient presented by superoxide dismutase as a part of cross-linked methoxy-poly(ethylene glycol)-poly(L-lysine) block copolymer nanoparticles, as well as to a method of treating inflammatory eye diseases using the given pharmaceutical compositions. The active ingredient content in the composition makes 50-500 kUnit/ml. The composition can be presented in the form of eye drops or a spray. In addition, the composition contain antibiotics, steroids, adrenoreceptor blocking agents, macro- and microelements, and vitamins. n EFFECT: group of inventions provides the intensified and prolonged anti-inflammatory action of superoxide dismutase on the eye diseases related to inflammatory processes. n 7 cl, 1 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2709536-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2733928-C2 |
| priorityDate | 2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.